-
Heel pain, another painful pain of ankylosing spondylitis
Time of Update: 2022-11-25
For patients with a family history of ankylosing spondylitis and frequent symptoms such as heel pain, it is necessary to see a doctor as soon as possible to improve HLA-B27, sacroiliac joint and spinal joint CT or MRI to diagnose as soon as possible.
-
Science Café Expert Review: Sleep to anxiety, listen to pain
Time of Update: 2022-11-01
。 SDS induces socially frustrated mice to sleep in the next few hours, and researchers such as researcher Yu Xiao from Imperial College London and Professor Dong Hailong's team at Xijing Hospital of the Fourth Military Medical University of China found that this restorative sleep activates a small number of nerve cells located in the ventral tegmental area (VTA) of the midbrain [1].
-
A&R: Recreational Physical Activity and Risk of Knee Osteoarthritis: An International Meta-Analysis of Individual Participant Data
Time of Update: 2022-05-13
RESULTS: Based on a total of 5065 participants, the pooled RR estimated the association of MET days per week with painful radiological OA ( RR 1.
Based on a total of 5065 participants, the pooled RR estimated the association of MET days per week with painful radiological OA ( RR 1.
-
Right or wrong
Time of Update: 2022-04-22
Researchers at The University of Texas MD Anderson Cancer Center have discovered that two distinct types of cancer-associated fibroblasts (CAFs) accumulate in the pancreatic cancer microenvironment and play opposite roles, either promoting or inhibiting pancreatic cancer progression.
-
Replaying the new crown era, those breakthrough therapeutic drugs that have to be said
Time of Update: 2022-03-06
This review article presents the most impactful breakthrough medical innovations in response to COVID-19, Ebola virus disease (EVD), heart disease, cancer, Alzheimer's disease, diabetes and malaria during the pandemic It has far-reaching significance and positive impact on human beings .
-
The latest clinical guidelines are released, and it is no longer difficult for patients with diabetic nephropathy to lower blood pressure
Time of Update: 2022-01-26
If the patient's serum potassium is ≥6mmol/L, ACEI or ARB should not be used or the dose should be reduced (not rated); ⑨ It is recommended for all patients with type 2 diabetes, advanced CKD and hypertension All patients should follow a low-sodium diet (1B) .
-
Li Zhihuan, Hua Hui’s research group and collaborators from the School of Physics observed the new nuclide 18Mg outside the proton drip line for the first time and found new evidence that the magic
Time of Update: 2022-01-10
Words for Java 18. 9" >Associate Professor Li Zhihuan and Professor Hua Hui of the Department of Technical Physics and the State Key Laboratory of Nuclear Physics and Nuclear Technology, Peking Univer
-
Patients with ASCVD and multiple complications, control sugar and ease work
Time of Update: 2022-01-10
LEADER study [3] confirmed that liraglutide significantly reduces the risk of major cardiovascular adverse events (MACE) by 13%, bringing long-term benefits to patients .
Diabetes patients with ASCVD or high cardiovascular risk factors may consider starting GLP-1RA therapy (such as liraglutide) [4] .
-
CANCER RES: Abnormal regulation of NEIL3 is associated with poor prognosis of liver cancer
Time of Update: 2021-09-05
The research team collected the tumor and non-tumor tissues of 202 patients with primary liver cancer who underwent hepatectomy from 2010 to 2015, randomly selected 80 pairs of tumors and matched non-tumor specimens, and used immunohistochemical staining to detect NEIL3 expression levels .
-
BMS azacitidine tablets approved by the EU: the first first-line oral maintenance therapy for patients with AML in remission
Time of Update: 2021-08-09
Data from the key QUAZAR AML-001 study showed that in patients with first remission of AML, Onureg first-line maintenance therapy showed significant overall survival (OS) and recurrence-free survival (RFS) benefits compared to placebo .
-
[Industry News] The first KRAS inhibitor was approved for the market, and it may become history
Time of Update: 2021-06-11
Click on the translational medicine website above to subscribe to our dry goods | Reliable | Practical May 28, 2021, FDA announced accelerated approval of KRAS inhibitor Lumakras (active ingredient sotorasib, AMG510) for the treatment of non-small cell lung cancer with KRAS-G12C mutation (NSCLC) patients, this is the first anti-cancer therapy targeting specific KRAS gene mutations.
-
Clin Gastroenterology H: Analysis of the role of tumor necrosis pathogen antagonists in patients with primary sclerotic bileitis
Time of Update: 2020-09-19
the researchers conducted retrospective analyses of 141 PSC and IBD patients treated with anti-tumor necrotic cause (TNF) (Invlixi monoantigen or Adamo monoantigen).
(Adamu monoantigen effect is better) This study reviewed 141 PSC and IBD patients and found that anti-TNF drugs were moderately effective and were not associated with increased PSC symptoms or specific side effects.
-
Natno Biotechl: Hematopoietic stem cell gene editing strategy update! More efficient and more applicable
Time of Update: 2020-07-29
!---- Hematopoietic Stem Cell (HSCs) Targeted Gene Editing is a promising and promising treatment for a wide range of diseases It can achieve in situ correction, functional restoration and physiologic
-
FDA grants Novartis crizanlizumab ground-breaking drug for the prevention of vascular blocking risk in patients with sickle cell disease
Time of Update: 2020-06-10
recently, Swiss Pharmaceutical (http:// giant Novartis announced that the U.S Food and Drug (http:// Authority ( FDA (http:// ) has awarded crizanlizumab (SEG101), formerly known as SelG1, t
